Neurxtem Neural Organoid Human Platform Development for Substance and Opioid Use Disorders — Rene Anand (NEURXSTEM, INC.)
This is a SBIR proposal from Neurxstem Inc., a company selected by NCET2 as a “Best University Startups 2016” is in response to the NIH HEAL initiative. Neurxstem’s goals are to develop and optimize a
| Project title | Neurxtem Neural Organoid Human Platform Development for Substance and Opioid Use Disorders |
|---|---|
| Project number | 4R44DA051281-02 |
| PI name | Rene Anand |
| Institution | NEURXSTEM, INC. |
| Funding mechanism | R44 |
| Agency | NIDA |
| Award amount | $1.07M |
| Fiscal year | 2021 |
| Project start | 2020-05-01T00:00:00 |
| Project end | 2023-01-31T00:00:00 |
| Abstract | This is a SBIR proposal from Neurxstem Inc., a company selected by NCET2 as a “Best University Startups 2016” is in response to the NIH HEAL initiative. Neurxstem’s goals are to develop and optimize a |
| Key terms | <AD dementia><Alzheimer><Alzheimer Type Dementia><Alzheimer disease><Alzheimer sclerosis><Alzheimer |
$799/mo
Try GrantRadar →